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Abstract  
Tyramine and histamine are the main dietary bioactive amines related to acute adverse health 
effects. Dry fermented sausages can easily accumulate high levels of these hazards and are 
frequently consumed in Spain. The present work aims to assess the exposure to tyramine and 
histamine from the consumption of dry fermented sausages by the Spanish population and to 
assess the risk to suffer acute health effects from this exposure. A probabilistic estimation of 
the exposure to these hazards was derived combining probability distributions of these amines 
in dry fermented sausages (n=474) and their consumption by the Spanish population. The mean 
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dietary exposure to tyramine and histamine was 6.2 and 1.39 mg/meal, respectively. The risk of 
suffering hypertensive crisis or histamine intoxication by healthy population due to tyramine or 
histamine intake, respectively, exclusively from dry fermented sausages, can be considered 
negligible. For individuals under treatment with MAOI drugs, the probability to surpass the safe 
threshold dose (6 mg/meal) was estimated as 34%. For patients with histamine intolerance, 
even the presence of this amine in food is not tolerable and it could be estimated that 7,000 
individuals per million could be at risk to suffer the related symptoms after consuming dry 
fermented sausages. 
 
Highlights: 
1. Exposure assessment to tyramine and histamine has been performed.  
2. Tyramine and histamine intake is not a health concern for the general Spanish population. 
3. Tyramine exposure from sausages could provoke adverse effects in MAOI treated patients. 
4. Histamine exposure levels from dry fermented sausages are crucial for histamine intolerants.  
 
Keywords: Tyramine; histamine; dry fermented sausages; risk assessment; histamine 
intolerance; bioactive amines. 
* Corresponding author: mcvidal@ub.edu
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1. Introduction 
Bioactive amines are microbial metabolites, which can be found in nearly all types of 
foods in a wide and variable range of concentrations, even within the same type of product. 
Fermented food and beverages, such as dry fermented sausages, constitute one of the food 
products that can accumulate high amine contents, which are formed by the decarboxylation of 
precursor amino acids by fermentative microorganisms as well as by spoilage microorganisms 
(EFSA, 2011; Bover-Cid et al., 2014). In the last decades, hygienic improvements at all stages of 
the food chain along with other specific recommendations, such as the use of starter cultures 
lacking amino acid-decarboxylase potential, might have contributed to reduce the levels of 
these compounds in fermented meat products. However, data on biogenic amine content in dry 
fermented sausages on the Spanish market indicate that there are still many products that 
contain high levels of amines (Latorre-Moratalla et al., 2012). In fact, different Member States 
of EU at the EFSA Network Meeting on Microbiological Risk Assessment informed about an 
increase of bioactive amine content in some fermented foods (EFSA, 2011). Therefore, the 
presence of these compounds in fermented foods could be still of concern from the food safety 
point of view (Leuschner et al., 2013). Dry fermented sausages are the most consumed 
fermented products in Spain, either as a snack or part of a main dish.  
Tyramine and histamine are the main dietary bioactive amines associated with adverse 
health effects. Adverse health effects can occur both in case of high intake of these amines or 
when the ability to metabolize them is compromised by different causes (including enzymatic 
deficiencies due to genetic or physiological circumstances or enzymatic blockage). Under these 
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circumstances they accumulate in plasma and exert bioactive effects (Maintz & Novak 2007; 
Ladero et al. 2010; Kovacova-Hanuskova et al., 2015). Tyramine may increase blood pressure, 
especially if its exposure coincides with the antidepressant monoamine oxidase inhibitors 
(MAOI) drugs (Paulsen et al., 2012, Vidal-Carou et al., 2014). Histamine intoxication, formerly 
called scombroid or histamine fish poisoning, is caused by the ingestion of high concentrations 
of this amine, so that normal metabolic mechanisms are insufficient for their detoxification. The 
symptoms associated with this intoxication are allergy-like, characterized by neurological and 
gastrointestinal effects such as headaches, nausea, vomiting, diarrhea, by cutaneous pruritus, 
flush and urticaria, and by rhinorrhea and hypotension. The severity of the disorders related to 
both tyramine and histamine exposure is variable, but it may be considered mild since only 
sometimes require medical attention. The frequent misdiagnosis is reported as the main reason 
accounting for the poor statistics about the incidence of health disorders due to dietary amines 
(FAO/WHO, 2013). 
Furthermore, the onset of symptoms related to histamine accumulation in blood has 
also been associated with a wide range of foods with relatively low histamine content. This is 
known as histamine intolerance, which derives from the insufficient activity of histamine 
detoxification systems, concretely a deficiency of DAO enzyme by genetic, pathological (e.g. 
inflammatory bowel diseases) or pharmacological blockade caused by the treatment with 
common drugs with known DAO inhibiting side effects (acetylcysteine, clavulanic acid and 
metoclopramide, etc.) (Jarisch, 2004; Maintz & Novak 2007). Although the symptoms of 
histamine intolerance are similar to those of intoxication, some authors associate DAO 
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deficiency with some diseases of high prevalence in the population, such as migraine, atopic 
dermatitis, irritable bowel syndrome, cyclic vomiting syndrome, and muscular pain (Guida et al., 
2000, Maintz & Novak 2007; Vidal-Carou et al., 2010, Izquierdo et al., 2012; Rosell-Camps et al., 
2013; Tormo, 2013; Kovacova-Hanuskova et al., 2015).  
The exposure assessment of any specific hazard is a key point on the risk assessment 
and data quality and treatment could have a significant impact on the risk estimation 
(FAO/WHO, 2013). Although the quantitative risk assessment is currently recognized as the 
relevant scientific approach to assess food safety and to provide scientific criteria for decision 
making in risk management and development of mitigation strategies, only few assessments 
have been performed regarding bioactive amines in food. Mainly, these assessments dealt with 
histamine in fish and fishery products (Lehaney & Olley et al., 2000; Sumner and Ross, 2002, 
FAO/WHO, 2013), and also tyramine, histamine, putrescine and/or cadaverine in fermented 
foods based on Austrian data (Rauscher-Gabernig et al., 2009; Paulsen et al., 2012, Rauscher-
Gabernig et al., 2012) and EU data (EFSA, 2011). The deterministic calculations (i.e. point 
estimates) of the bioactive amine exposure used in most of the above mentioned studies, did 
not provide exposure level probability. However, a stochastic approach would provide a more 
representative exposure assessment and hence, a more realistic risk assessment. Therefore, the 
current work aims to assess the exposure of Spanish consumers to tyramine and histamine 
from dry fermented sausages by means of a probabilistic estimation, and to quantify until 
which extend such exposure contributes to reach the maximum tolerable levels generally 
recognised as safe. 
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2. MATERIALS AND METHODS  
2.1. Data on tyramine and histamine contents in dry fermented sausages from the Spanish 
market.  
Data about contents of tyramine and histamine in dry fermented sausages from retail 
Spanish market were obtained from the database of our own research group (Vidal-Carou et al., 
1990; Hernández-Jover et al., 1997; Bover-Cid et al., 1999; Miguélez-Arrizado et al., 2006; 
Latorre-Moratalla et al., 2008; Latorre-Moratalla et al., 2012). A total of 474 samples of 
different kinds of dry fermented sausages were considered: Salchichón (n= 357), chorizo (n= 
87), salami (n= 18) and sobrasada (n= 12). All these products are manufactured by 
fermentation and ripening from pork meat and fat with other additional ingredients (e.g. 
pepper or red pepper, sugar, wine, garlic, preservatives, etc.) with or without the addition of 
starter cultures. The determination of bioactive amines in all samples was performed by ion-
pair HPLC or UHPLC methods coupled to fluorescence detection (Hernández-Jover et al., 1996, 
Lavizzari et al., 2006, Latorre-Moratalla et al., 2009).  
 
2.2. Data on consumption of dry fermented sausages by Spanish population 
Data about consumption of dry fermented sausages was extracted from the Spanish 
national dietary survey (Encuesta Nacional de Ingesta Dietética) carried out by the Spanish 
Agency for Consumer Affairs, Food Safety and Nutrition (AECOSAN, 2011). This survey includes 
a sample of 3000 individuals randomly selected within the Spanish population, 1500 men and 
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1500 women aged between 18 and 64 years old. Consumption data (i.e. serving size) of the 
selected food categories (salchichón, chorizo, salami and sobrasada) were expressed in grams. 
As the toxic effects of tyramine and histamine are of acute nature, the intake was calculated on 
a meal basis (i.e. grams per meal per person). Only the meals where dry fermented sausages 
were consumed were considered.  
 
2.3. Exposure assessment 
Various probability distributions were fitted to tyramine and histamine contents of 
Spanish dry fermented sausages and consumption data collected from Spanish population using 
@Risk 7.0 (Palisade Corporation, NewField, NY). The goodness of fit was evaluated using the 
Chi-square (χ2) test. The best-fitting distributions describing tyramine or histamine contents and 
dry fermented sausage consumption were selected as an input for the assessment of the 
exposure to these compounds by the probabilistic estimation using the Monte Carlo simulation 
technique with 10,000 iterations.  
 
2.4. Hazard characterization  
The maximum tolerable safety levels as an approximation of the no adverse health 
effect level adopted in the EFSA Scientific Opinion (EFSA, 2011) for different types of population 
were considered. These threshold limits were obtained from studies published in the literature 
based on toxicological data of dietary amines, clinical studies with volunteers, clinical cases and 
other expert opinions about tolerance or intoxication levels. For tyramine the thresholds were: 
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6 mg/meal/person for patients treated with MAOI drugs, 50 mg/meal/person for patients 
receiving third generation of MAOI drugs, so called RIMA (reversible inhibitors of MAO-A); and 
600 mg/meal/person for healthy individuals. For histamine, the safe threshold considered for 
healthy population was 25 mg/meal/person as the most conservative level. In the case of 
patients with histamine intolerance, even small amounts of this amine in food may cause 
adverse effects, so as the EFSA (2011) stated, “only levels below detectable limits can be 
considered as safe”. 
To quantify the contribution of the exposure to tyramine and histamine from dry 
fermented sausages to reach the maximum tolerable levels for healthy and sensitive population 
a ratio between the exposure level and those thresholds was calculated. 
 
3. RESULTS AND DISCUSSION 
3.1. Distribution of tyramine and histamine contents in dry fermented sausages from the 
Spanish market.  
Figure 1 shows the distribution of tyramine contents (mg/kg) in retail Spanish dry 
fermented sausages. Tyramine was the most frequent and abundant bioactive amine found in 
retail dry fermented sausages (detected in the 99.5% of samples) following a lognormal 
distribution with the parameter estimates shown in Table 1. The mean value was 139 mg/kg 
(relative standard deviation, RSD of 86%) and the range was from not detected (<0.01 mg/kg) 
to 742 mg/kg, though 95% of samples did not exceed 400 mg/kg. No significant differences 
were found among contents of tyramine depending on the type of sausage (p>0.05), neither no 
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significant trend was found when assessing tyramine contents as a function of years. Tyramine 
is extensively reported as the main bioactive amine found in dry fermented sausages, in which 
is usually produced by fermentative microbial population, mainly lactic acid bacteria (LAB) and 
more rarely coagulase negative staphylococci (Aymerich et al., 2006; Talon & Leroy, 2011; 
Latorre-Moratalla et al., 2012). Latorre-Moratalla et al. (2010) reported that 48% of LAB and 
13% of staphylococci isolated from spontaneously dry fermented sausage are able to 
decarboxylate tyrosine to form tyramine. Likewise some strains of spoilage microbiota have 
also been described as strongly tyraminogenic (Latorre-Moratalla et al., 2012).  
The occurrence of histamine in retail Spanish dry fermented sausages was less frequent 
(in the 66% of samples) and usually at lower levels than tyramine. Histamine contents followed 
a beta general distribution (Table 1). The mean value was 27 mg/kg (RSD of 215%) and the 95-
percentil 143 mg/kg (Figure 2). Among samples containing histamine, 57% did not exceed 10 
mg/kg. In some particular samples, high histamine contents were found, reaching 475 mg/kg 
generally accompanied by high amounts of other bioactive amines, such as tyramine, 
putrescine and cadaverine (data not shown). Chorizo sausage showed the highest histamine 
levels, although the mean value was not statically different when compared with the other 
products (p>0.05). As in the case of tyramine, histamine contents were not significantly 
different according to the year of analysis. Some strains of a reduced number of enterobacteria 
or LAB have the capability to produce histamine in dry fermented sausages. However, the 
presence of these specific bacteria in this kind of food is not very common unless specific 
contaminations occur (Roig-Sagués et al., 1996; Bover-Cid et al., 2001). Therefore, high 
 10 
 
contents of this amine in dry fermented sausages are usually considered as a hygienic indicator 
of poor microbiological quality of raw materials and/or improper manufacturing processes.  
The large variability of tyramine and histamine contents observed in retail Spanish dry 
fermented sausages could be explained by multiple factors such as the microbiological quality 
of raw materials, which varies in each production batch; ingredients and additives (sugar, curing 
agents, spices, etc.). Additionally, diameter of sausage and technological ripening conditions 
(temperature and relative humidity) can also influence the phenomena associated with 
aminogenesis, including microbial growth, acidification, proteolysis and activity of 
decarboxylases (Suzzi & Gardini,  2003; Spano et al., 2010; Singh et al., 2012). Therefore, the 
probabilistic exposure assessment from data about biogenic amine in retail products becomes 
the most suitable approach to capture and deal with the actual variability of the occurrence of 
these hazards.   
 
3.2. Distribution of the consumption of dry fermented sausages.  
According to the last extensive national dietary survey performed in Spain (AECOSAN, 2011) a 
wide variability in the amount of sausage consumption was recorded, ranging from 2 to more 
than 250 g/meal. The mean consumption was 45 g/meal (RSD of 73%) and the 95-percentile 
100 g/meal (Figure 3). Consumption data described a gamma distribution (Table 1). According 
to this survey, the 19% of meals contain some kind of dry fermented sausages as starter, main 
dish or snack, although the serving size changed in each case. Concretely, the product most 
often consumed is chorizo (about once a week) with a mean value of 42 g/meal/person. 
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Salchichón sausages type is consumed less frequently (about once every 3 weeks) but in higher 
amounts (mean of 52 g/meal). Sobrasada and salami are more sporadically consumed but in 
similar amounts to salchichón. No statistically significant differences were detected in 
consumption according to age or gender of consumers. 
 
3.3 Exposure assessment and hazard characterization of tyramine 
The outputs of the probabilistic exposure assessment for tyramine performed by combining 
probability distributions of tyramine contents and sausages consumption are shown in Figure 4.  
The exposure to tyramine from dry fermented sausages followed a Pearson5 distribution (Table 
1). The mean value for tyramine exposure was 6.2 mg/meal (RSD of 124%). In the 95% of meals 
involving dry fermented sausages, the exposure to tyramine was below 21 mg, whereas the 
maximum level was 93 mg/meal.  
In the assessment carried out by EFSA, tyramine exposure data on dry fermented sausages from 
Spain is not available and only a total European 95-percentile was reported, ranging from 17.2 
to 99.3 mg/day, depending on the country (EFSA, 2011). Also considering the high level 
exposure (95-percentile) to tyramine of the Spanish population (21 mg/meal), this data is 
placed in the lower European range determined by the EFSA. This lower intake of tyramine per 
meal could be attributed to lower serving size of these products by the Spanish population in 
comparison with other EU countries, as the occurrence of tyramine in Spanish dry fermented 
sausages is similar in both assessments. 
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Table 2 shows the contribution of the exposure to tyramine from Spanish dry fermented 
sausages to achieve the maximum tolerable levels for healthy population and for vulnerable 
population under treatment with MAOI or RIMA drugs. The quantification was performed by 
different exposure estimations: mean, 95-percentile and maximum values. On the basis of the 
results obtained regarding the tyramine exposure, the risk of suffering a hypertensive crisis by 
the healthy population was negligible. In fact, even if it is considered a high tyramine exposure 
(95-percentile and maximum) only a 4 and 16% of the maximum tolerable amount (600 
mg/meal) was reached, respectively. Although this contribution is apparently low, it must be 
taken into account that meals may also contain other food with variable bioactive amine levels 
(e.g. cheese, wine, etc.). The assessment of the overall exposure to tyramine by the multiple 
sources of this bioactive amine remains unknown.  
In the case of people under treatment with RIMA drugs, the 95-percentile of exposure of 
tyramine (21 mg/meal) meant the 42% of the maximum tolerable level. The probability to reach 
an exposure of 50 mg of tyramine in a meal was very low (0.01%) and only this threshold limit 
was exceeded with the maximum value of tyramine exposure (92.5 mg/meal). The situation is 
different in those individuals treated with MAOI drugs, in which the mean exposure to tyramine 
by the consumption of sausages already exceeded the safe dose (6 mg/meal). According to the 
tyramine exposure output, the probability to surpass this tolerable exposure level per meal was 
estimated to be 34%.   
According to the last report on antidepressant drug consumption by the Spanish population 
published by the Spanish Agency on Medicinal Products, the only MAOI and RIMA drugs used 
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for the treatment of depression are tranylcypromine and moclobemide. Nowadays, up to 
0.001% of the Spanish population is receiving a daily dose of these drugs, being used only as an 
alternative therapy in depressive patients resistant to more frequently used antidepressants 
(AEMPS, 2015). In view of this data and taking into account that approximately 46 million 
people in Spain are potential consumers of dry fermented sausages (i.e. total Spanish 
population excluding the 1.5% reported as not consumers of meat products according to ENIDE 
survey), 3 individuals per million (i.e. 156 individuals) would be daily exposed to a level of 
tyramine above the maximum tolerable threshold when taking MAOI drugs. However patients 
prescribed with MAOI and RIMA are usually advised to limit or avoid the consumption of dry 
fermented sausages. Therefore, as MAOI treated individuals could have consumption-patterns 
different from the data used in the present assessment (from mostly non MAOI treated 
people), the actual exposure to tyramine of this vulnerable population will be most probably 
lower than the above estimation. 
 
3.4 Exposure assessment and risk characterization of histamine 
The outputs of the probabilistic exposure assessment for histamine performed by combining 
probability distributions of histamine contents and sausages consumption are shown in Figure 
5. Levels of exposure to histamine from the consumption of dry fermented sausages followed a 
lognormal distribution (Table 1) with a mean value of 1.39 mg/meal (RSD of 228%). Only 5% of 
meals resulted in histamine intake levels higher than 6.8 mg. As in the case of tyramine, in the 
European exposure assessment histamine exposure data specifically for Spain is not available. 
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The total European 95-percentile reported for histamine exposure in these type of products 
was from 6.4 to 37.1 mg/day, depending on the country (EFSA, 2011). Spanish exposure levels 
obtained in the present assessment are clearly placed within the lower interval, which could be 
explained, as in the case of tyramine, by the lower consumption of these products by the 
Spanish population in comparison with those reported for the European population. 
Table 3 shows the contribution (percentage) of the exposure to histamine from dry fermented 
sausages to achieve the maximum tolerable level adopted for preventing histamine intoxication 
(25 mg/meal). Considering the mean exposure, only the 6% of the critical threshold was 
reached, and even considering 95-percentile of the exposure less than the 30% of this limit was 
reached. Based on the present results, the risk to suffer acute effects related to histamine by 
the consumption of Spanish dry fermented sausages is really low, since only in very rare 
occasions (maximum exposure value) the threshold was nearly doubled.  
An additional concern associated with the occurrence of histamine in food is for people 
suffering from histamine intolerance, in which even the presence of this amine at very low 
levels is considered to be capable of triggering adverse effects. This intolerance related to a 
deficiency in the metabolism of histamine due to the lack of specific enzymes, what produces 
its accumulation in plasma and the appearance of multi-faced clinical symptoms. For this 
reason, for individuals with histamine intolerance only food with levels of this amine below 
detectable limit could be considered as safe (EFSA, 2011). Moreover, it should be taken into 
account that the occurrence of dietary potentiators, such as other bioactive amines or alcohol 
and its metabolite acetaldehyde, could also increase or enhance the susceptibility to histamine 
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and, accordingly, the risk of adverse reactions could rise (Maintz & Novak, 2007). In the dry 
fermented sausages from the Spanish market considered in this study, the 66% contained 
histamine, and very frequently accompanied with other potentiate bioactive amines such as 
putrescine and cadaverine. 
Some studies estimate that histamine intolerance may affect 1% of the general population 
(Maintz & Novak, 2007; Kovacova-Hanuskova et al., 2015). However, the increasingly 
widespread diagnosis of histamine intolerance by DAO deficiency could augment this 
population percentage. In fact, it has been published recently more evidence about the 
relationship between a reduced capacity to metabolize dietary histamine by a deficit of DAO 
and health problems such as migraine, gastrointestinal disorders, skin reactions and muscle 
pain, among others (Guida et al., 2000, Vidal-Carou et al., 2010, Izquierdo et al., 2012; Rosell-
Camps et al., 2013; Tormo, 2013). Some recent interventional studies have shown a high 
incidence rate of DAO deficiency (up to 80%) among this type of susceptible population 
(Izquierdo et al., 2012; Rosell-Camps et al., 2013). In addition, it should be considered that 
histamine intolerance can be a consequence of inhibition of DAO activity as a side effect caused 
by a number of commonly used drugs, including acetylcysteine, clavulanic acid, 
metoclopramide, verapamil, isoniazid, etc. (Maintz & Novak 2007, Kovacova-Hanuskova et al., 
2015). Indeed, it was estimated that approximately 20% of the European population could be 
taking some of the DAO inhibitor drugs (EFSA, 2011).  
Considering that 46 million people in Spain are potential consumers of dry fermented sausages 
and that the histamine intolerance could affect at least the 1% of the population and taking into 
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account the estimation that the 66% of retail dry fermented sausages contained histamine 
(percentage obtained in the present study), it could be expected that the 0.7% of Spanish 
population (303,600 individuals) may suffer some of the related symptomatology after the 
consumption of dry fermented sausages. Moreover, it should be taken into account the 
existence of other potential sources of histamine, such as cheese, fish or fish products, 
fermented beverages and some vegetables, that are fairly widespread making the risk of 
suffering this intolerance higher. 
 
4. Conclusions 
A reliable estimation of exposure has been achieved through the probabilistic assessment from 
representative Spanish data of amine contents and consumption of dry fermented sausages, in 
which the actual distribution of the content of the hazard and the mathematical function 
describing the probability of occurrence of every value is described. According to this 
probabilistic estimation, tyramine and histamine intake would hardly contribute to reach their 
maximum tolerable threshold for healthy individuals. However, sensitive people treated with 
MAOI drugs or with histamine intolerance by deficit of DAO would be at risk of suffering 
adverse effects due to the consumption of dry fermented sausages. Concretely, the maximum 
tolerable limit established for patients under MAOI treatment (6mg/meal) was exceeded in the 
34% of meals containing dry fermented sausages. Therefore, it could be estimated that 3 
habitants per million of the Spanish population could suffer adverse health effects due to the 
exposure to tyramine from dry fermented sausages and the concomitant consumption of MAOI 
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drugs. This estimated risk is very low compared with that found for individuals with histamine 
intolerance, which rises up to practically 7,000 cases per million habitants.  
Due to the estimated risk of suffering adverse effects attributed to histamine in food, it seems 
important that food industry accepts the challenge to proceed with measures focussed on the 
minimization of the occurrence of histamine in food. This implies to control the potentially 
aminogenic microorganisms, its growth and its amino acid-decarboxylase activity during the 
whole production and merchandising chain. Moreover, the statement of tyramine and 
histamine content in food labelling would be another additional measure to prevent the 
occurrence of the related adverse effects of those bioactive amines in sensitive individuals, 
especially for histamine intolerant individuals. Additional studies are needed to estimate the 
maximum level of histamine and eventually other amines in food to provide histamine 
intolerant patients with clearly labelled products. 
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TABLE 1.  Distributions used as inputs for the exposure assessment model and the resulting 
outputs for dietary exposure of consumers to tyramine and histamine. 
 
 Distributional assumptiona 
Inputs 
Tyramine contents (mg/kg) Log Normal (178.26b;128.74c; shift [-37.832]) 
Histamine contents (mg/kg) Beta General (0.19d;10.79e; 0.01f; 1510.4g) 
Consumption (g/serving size) Gamma (1.97h; 22.1i; shift [1.90]) 
Outputs  
Exposure of tyramine (mg/meal)  Pearson5 (2.70h; 14.75i; Shift [-2.4]) 
Exposure of histamine (mg/meal)  Log Normal (6.77; 304.2; Shift [-0.000005]) 
aProbability distributions best fitting available data (lowest χ2 according to @risk) 
b Mean; c Standard deviation 
d α1; e α2, f Minimum, g Maximum 
h Shape α, i Scale β 
 
  
TABLE 2.  Contribution (%) of the tyramine exposure from dry fermented sausages by the Spanish 
population to achieve the maximum tolerable levels generally adopted as safe by EFSA for the 
healthy population and for vulnerable people under treatment with RIMA (reversible inhibitor of 
monoamine oxidase A) or MAOI (monoamine oxidase inhibitor) drugs*. 
 
Tyramine exposure 
(mg/meal) 
Contribution (%) 
Healthy Population   RIMA patients MAOI patients 
Mean 6.2 1  12 103 
95-Percentile 21 4  42 350 
Maximum 92.5 16  185 1540 
 
* 600 mg/meal for healthy population, 50 mg/meal for patients treated with RIMA drugs and 6 
mg/meal for patients treated with MAOI drugs. 
  
TABLE 3.  Contribution (%) of the histamine exposure from dry fermented sausages by the Spanish 
population to achieve the maximum tolerable levels generally adopted as safe by EFSA for the 
healthy population (histamine intoxication) and for histamine intolerance*. 
 
Histamine exposure 
(mg/meal) 
Contribution (%) 
Healthy Population   Histamine Intolerance patients
a 
Mean 1.4 6  - 
95-Percentile 6.8 27  - 
Maximum 45.8 183  - 
 
* 25 mg/meal for healthy population.  
a According to EFSA, for people with histamine intolerance even small amounts of histamine may 
cause adverse health effects and no maximum tolerable threshold has been adopted. Therefore, 
no contribution has been calculated. 
 
		
Figure	1.	Distribution	of	tyramine	contents	(mg/kg)	in	Spanish	dry	fermented	sausages				
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Figure	2.	Distribution	of	histamine	contents	(mg/kg)	in	Spanish	dry	fermented	sausages.			
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Figure	3.	Distribution	of	dry	fermented	sausage	consumption	by	the	Spanish	population	(g/meal)			
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Figure	4.	Results	of	tyramine	exposure	(mg/meal)	from	dry	fermented	sausages	by	the	Spanish	population.		
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Figure	5.	Results	of	histamine	exposure	(mg/meal)	from	dry	fermented	sausages	by	the	Spanish	population.			
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